NCT04068259View on ClinicalTrials.gov

Single Ascending Dose Study of PBI-4547 in Healthy Subjects

PHASE1TerminatedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

September 5, 2019

Primary Completion Date

October 8, 2019

Study Completion Date

October 8, 2019

Conditions

Healthy Subjects

Interventions

DRUG

PBI-4547

PBI-4547 tablet

OTHER

Placebo

Placebo tablet

Trial Locations (2)

H3X 2H9

Syneos Health, Montreal

G1P 0A2

Syneos Health, Québec

Sponsors

Lead Sponsor

Liminal BioSciences Ltd.

Collaborators (1)

All Listed Sponsors

collaborator

Syneos Health

OTHER

lead

Liminal BioSciences Ltd.

INDUSTRY